| abstract |
A compound of formula (I), which is 2 - [(4S) -6- (4-chlorophenyl) -1-methyl-8- (methyloxy) -4H- [1,2,4] triazolo [4,3- a] [1,4] benzodiazepin-4-yl] -N-ethylacetamide ** (See formula) ** or a pharmaceutically acceptable salt thereof for use in the treatment of a fibrotic condition, a viral infection or a disease or condition that involves an inflammatory response to infections. |